Pharmacy to offer Pfizer/BioNTech vaccine to those not eligible for NHS booster shot from next week

The former president of Brazil is a staunch opponent of Covid-19 vaccines

Researchers say jabs substantially reduce for up to a year the chances of serious cardiovascular complications

The 62-year-old, from Germany said he had the large number of vaccines for ‘private reasons’, researchers said

The recommendations by Dr Clive Dix also include the creation of a National vaccines Agency.

Results confirm how uncommon known complications are as researchers confirm benefits from vaccines still ‘vastly outweigh the risks’

This spring those at the highest risk will miss out on the jab. Meanwhile, the government will be throwing away vaccines, says immunologist Sheena Cruickshank

Putin did not specify which types of cancer the proposed vaccines would target, nor how

Rishi Sunak was subjected to a man’s furious rant over the Covid vaccine during a live forum on GB News on Monday (13 February). John Watt, gestured towards the prime minister as he claimed he was among 30,000 that had suffered side effects as a re ...

Two decades of work in the field of cancer vaccines finally starting to bear fruit, experts say

Resurgence classified as grade 3 emergency by WHO, with southern Africa and Haiti among those hardest hit

‘These vaccines are not appropriate for use in human beings,’ Dr Ladapo wrote

Research by a team led by Sean O’Leary, MD, shows that parental vaccine hesitancy remained unchanged during COVID-19, but trust levels vacillated.

Llama nanobodies may offer an option for treating norovirus, a global health problem for which there are no vaccines or antiviral drugs.

African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut HIV risk

Vaccinations could be made less painful by treating skin with a vaccine-laden liquid and using ultrasound to push it into the body

 

Antibodies targeting the HIV-1 fusion peptide rarely achieve more than 60% neutralization breadth. Here, the authors develop an anti-FP antibody enhancing its potency to 80% and structurally resolve the expanded FP-binding site that allows the antibo ...